If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

AKRO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.38%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $89,596,406.33

Akero Therapeutics Insider Trading History Chart

Akero Therapeutics Share Price & Price History

^$37.80

▼ -2.5 (-6.20%)

As of 03/30/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Akero Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/1/2023	Andrew Cheng	CEO	Sell	25,000	$46.65	$1,166,250.00	370,999
2/1/2023	Andrew Cheng	CEO	Sell	25,000	$49.06	$1,226,500.00	370,999
1/13/2023	Catriona Yale	Insider	Sell	5,000	$50.53	$252,650.00	81,268
1/3/2023	Andrew Cheng	CEO	Sell	25,000	$51.27	$1,281,750.00	370,999
1/3/2023	Jonathan Young	COO	Sell	8,777	$54.64	$479,575.28	184,911
12/28/2022	Timothy Rolph	Insider	Sell	1,700	$50.00	$85,000.00	203,032
12/28/2022	William Richard White	CFO	Sell	999	$49.76	$49,710.24	23,624
12/27/2022	Jonathan Young	COO	Sell	12,500	$49.57	$619,625.00	182,449
12/12/2022	Catriona Yale	Insider	Sell	5,000	$43.23	$216,150.00	86,268
12/1/2022	Andrew Cheng	CEO	Sell	10,000	$46.07	$460,700.00	310,148
12/1/2022	Skorpios Trust	Major Shareholder	Sell	1,636,000	$43.50	$71,166,000.00	3,271,829
11/30/2022	Seth Loring Harrison	Director	Sell	11,101	$46.94	$521,080.94	136,301
11/15/2022	Timothy Rolph	Insider	Sell	3,138	$45.04	$141,335.52	187,784
11/10/2022	Catriona Yale	Insider	Sell	5,000	$39.42	$197,100.00	72,073
11/1/2022	Andrew Cheng	CEO	Sell	10,000	$43.42	$434,200.00	310,148
10/27/2022	Seth Loring Harrison	Director	Sell	66,426	$41.53	$2,758,671.78	168,540
10/25/2022	Jonathan Young	COO	Sell	12,500	$44.72	$559,000.00	163,254
10/25/2022	Seth Loring Harrison	Director	Sell	4,515	$44.92	$202,813.80	300,851
10/25/2022	Timothy Rolph	Insider	Sell	10,653	$45.09	$480,343.77	195,684
10/13/2022	William Richard White	CFO	Sell	20,000	$39.82	$796,400.00	4,429
10/10/2022	Catriona Yale	Insider	Sell	5,000	$37.99	$189,950.00	77,073
10/6/2022	Timothy Rolph	Insider	Sell	22,500	$39.29	$884,025.00	186,337
10/3/2022	Andrew Cheng	CEO	Sell	10,000	$33.23	$332,300.00	310,148
9/30/2022	Timothy Rolph	Insider	Sell	45,000	$32.72	$1,472,400.00	198,837
9/13/2022	Andrew Cheng	CEO	Sell	60,000	$27.42	$1,645,200.00	310,148
9/13/2022	Catriona Yale	Insider	Sell	40,000	$27.48	$1,099,200.00	82,073
9/13/2022	William Richard White	CFO	Sell	32,500	$27.03	$878,475.00	4,429
3/1/2022	Andrew Cheng	CEO	Sell	10,000	$17.59	$175,900.00
2/1/2022	Andrew Cheng	CEO	Sell	10,000	$17.56	$175,600.00
1/14/2022	William Richard White	CFO	Sell	9,700	$22.03	$213,691.00
1/10/2022	Andrew Cheng	CEO	Sell	10,000	$19.55	$195,500.00
12/21/2021	William Richard White	CFO	Sell	100	$22.00	$2,200.00
12/17/2021	William Richard White	CFO	Sell	3,200	$22.04	$70,528.00
11/3/2021	Jonathan Young	COO	Sell	18,780	$24.27	$455,790.60
10/15/2021	Catriona Yale	Insider	Sell	12,500	$21.59	$269,875.00
8/16/2021	Catriona Yale	Insider	Sell	10,000	$18.79	$187,900.00	145,921
8/3/2021	Andrew Cheng	CEO	Sell	17,500	$20.83	$364,525.00
8/2/2021	William Richard White	CFO	Sell	4,441	$22.03	$97,835.23	7,718
7/15/2021	Catriona Yale	Insider	Sell	10,000	$20.90	$209,000.00
7/6/2021	William Richard White	CFO	Sell	6,500	$24.52	$159,380.00	9,777
7/2/2021	Andrew Cheng	CEO	Sell	17,500	$24.78	$433,650.00
6/1/2021	Kevin Bitterman	Director	Sell	17,489	$26.28	$459,610.92
4/1/2021	Jonathan Young	COO	Sell	3,055	$28.75	$87,831.25	170,120
4/1/2021	William Richard White	CFO	Sell	50,000	$28.64	$1,432,000.00	52,270
3/1/2021	Jonathan Young	COO	Sell	3,055	$30.48	$93,116.40	173,375
2/1/2021	Jonathan Young	COO	Sell	3,055	$29.24	$89,328.20
1/8/2021	Jonathan Young	COO	Sell	10,000	$28.12	$281,200.00	189,285
1/4/2021	Jonathan Young	COO	Sell	3,060	$25.29	$77,387.40	181,885
10/9/2020	Kevin Bitterman	Director	Sell	13,000	$28.93	$376,090.00
7/10/2020	Apple Tree Partners Iv, L.P.	Major Shareholder	Buy	415,000	$36.00	$14,940,000.00
7/6/2020	Global Strategic Fund I Venbio	Major Shareholder	Sell	4,603	$33.83	$155,719.49
7/1/2020	Global Strategic Fund I Venbio	Major Shareholder	Sell	108,064	$34.45	$3,722,804.80

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Akero Therapeutics (NASDAQ:AKRO)

97.76% of Akero Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Akero Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/23/2023	MetLife Investment Management LLC	18,279	$1M	0.0%	+17.3%	0.039%
2/28/2023	Voya Investment Management LLC	36,765	$2.02M	0.0%	+235.8%	0.079%
2/16/2023	Alliancebernstein L.P.	34,580	$1.90M	0.0%	+41.0%	0.074%
2/15/2023	Metropolitan Life Insurance Co NY	2,156	$0.12M	0.0%	+21.4%	0.005%
2/15/2023	MetLife Investment Management LLC	18,279	$1M	0.0%	+17.3%	0.039%
2/15/2023	IHT Wealth Management LLC	4,715	$0.26M	0.0%	N/A	0.010%
2/15/2023	State of Wisconsin Investment Board	28,668	$1.57M	0.0%	+54.3%	0.061%
2/15/2023	Schonfeld Strategic Advisors LLC	98,156	$5.38M	0.0%	+1,002.9%	0.210%
2/15/2023	Squarepoint Ops LLC	27,036	$1.48M	0.0%	N/A	0.058%
2/15/2023	Legal & General Group Plc	13,229	$0.73M	0.0%	+29.2%	0.028%
2/15/2023	Millennium Management LLC	247,017	$13.54M	0.0%	N/A	0.528%
2/15/2023	Morgan Stanley	207,000	$11.34M	0.0%	+7.1%	0.443%
2/15/2023	Norges Bank	174,900	$9.59M	0.0%	N/A	0.374%
2/15/2023	E Fund Management Co. Ltd.	9,604	$0.53M	0.0%	N/A	0.021%
2/15/2023	EAM Global Investors LLC	33,509	$1.84M	0.5%	-39.7%	0.072%
2/15/2023	EAM Investors LLC	53,512	$2.93M	0.6%	-36.8%	0.114%
2/15/2023	Algert Global LLC	13,908	$0.76M	0.0%	N/A	0.030%
2/15/2023	Alkeon Capital Management LLC	3,243,915	$177.77M	0.7%	+2.6%	6.937%
2/15/2023	Alps Advisors Inc.	31,725	$1.74M	0.0%	+54.4%	0.068%
2/15/2023	AQR Capital Management LLC	13,683	$0.75M	0.0%	N/A	0.029%
2/15/2023	Atlas Venture Life Science Advisors LLC	594,251	$32.57M	3.9%	-40.2%	1.271%
2/15/2023	Avidity Partners Management LP	3,825,000	$209.61M	4.5%	+22.5%	8.180%
2/14/2023	Price T Rowe Associates Inc. MD	2,401,037	$131.58M	0.0%	+64.2%	5.135%
2/14/2023	Marshall Wace LLP	1,503,364	$82.38M	0.2%	+100.2%	3.215%
2/14/2023	Two Sigma Investments LP	42,322	$2.32M	0.0%	-68.3%	0.091%
2/13/2023	Charles Schwab Investment Management Inc.	236,597	$12.97M	0.0%	+11.1%	0.506%
2/13/2023	Deutsche Bank AG	427,683	$23.44M	0.0%	+3,260.7%	0.915%
2/13/2023	Wells Fargo & Company MN	1,817	$100K	0.0%	-104.5%	0.004%
2/13/2023	Barclays PLC	103,552	$5.67M	0.0%	+8,616.5%	0.221%
2/13/2023	Renaissance Technologies LLC	67,600	$3.70M	0.0%	+5.5%	0.145%
2/13/2023	The Manufacturers Life Insurance Company	55,243	$2.99M	0.0%	+131.9%	0.118%
2/13/2023	Credit Suisse AG	26,639	$1.46M	0.0%	+105.3%	0.057%
2/13/2023	Geode Capital Management LLC	633,380	$34.71M	0.0%	+21.0%	1.355%
2/13/2023	American Century Companies Inc.	10,141	$0.56M	0.0%	N/A	0.022%
2/13/2023	GSA Capital Partners LLP	5,106	$0.28M	0.0%	N/A	0.011%
2/13/2023	Teacher Retirement System of Texas	8,761	$0.48M	0.0%	+3.8%	0.019%
2/10/2023	Bank of America Corp DE	202,389	$11.09M	0.0%	+187.8%	0.433%
2/10/2023	American International Group Inc.	16,491	$0.90M	0.0%	+24.0%	0.035%
2/10/2023	Amalgamated Bank	4,603	$0.25M	0.0%	+26.1%	0.010%
2/10/2023	Sei Investments Co.	15,278	$0.84M	0.0%	-4.2%	0.033%
2/10/2023	Victory Capital Management Inc.	4,087	$0.22M	0.0%	-78.7%	0.009%
2/10/2023	Advisor Group Holdings Inc.	1,135	$62K	0.0%	-20.3%	0.002%
2/10/2023	Artisan Partners Limited Partnership	238,465	$13.07M	0.0%	N/A	0.510%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	16,284	$0.89M	0.0%	+25.5%	0.035%
2/9/2023	Chicago Partners Investment Group LLC	25,994	$1.18M	0.1%	-13.9%	0.056%
2/9/2023	Victory Capital Management Inc.	4,050	$0.20M	0.0%	-78.9%	0.009%
2/9/2023	Dimensional Fund Advisors LP	290,606	$15.93M	0.0%	-0.3%	0.621%
2/9/2023	Principal Financial Group Inc.	9,347	$0.51M	0.0%	+32.4%	0.020%
2/9/2023	Citigroup Inc.	83,059	$4.55M	0.0%	+3,677.1%	0.178%
2/8/2023	Belpointe Asset Management LLC	1,730	$95K	0.0%	N/A	0.004%
2/8/2023	Swiss National Bank	71,000	$3.89M	0.0%	+2.6%	0.152%
2/8/2023	Arizona State Retirement System	8,302	$0.46M	0.0%	N/A	0.018%
2/7/2023	State Board of Administration of Florida Retirement System	9,460	$0.52M	0.0%	-5.4%	0.020%
2/7/2023	Skorpios Trust	3,271,829	$179.30M	57.0%	-33.3%	6.997%
2/7/2023	Handelsbanken Fonder AB	6,900	$0.38M	0.0%	N/A	0.015%
2/7/2023	TD Asset Management Inc	52,422	$2.87M	0.0%	+174.1%	0.112%
2/6/2023	Parallel Advisors LLC	5,783	$0.32M	0.0%	-4.1%	0.012%
2/2/2023	SG Americas Securities LLC	5,851	$0.32M	0.0%	-63.7%	0.013%
2/2/2023	Nisa Investment Advisors LLC	103,021	$5.65M	0.0%	+490,476.2%	0.220%
2/2/2023	Bailard Inc.	7,227	$0.40M	0.0%	-20.8%	0.015%
2/2/2023	ProShare Advisors LLC	8,353	$0.46M	0.0%	+33.7%	0.018%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	6,536	$0.36M	0.0%	+77.4%	0.014%
1/31/2023	Woodmont Investment Counsel LLC	7,570	$0.42M	0.0%	-21.3%	0.016%
1/30/2023	New York State Common Retirement Fund	32,629	$1.79M	0.0%	+61.2%	0.070%
1/24/2023	MUFG Securities EMEA plc	115,000	$6.30M	0.1%	N/A	0.246%
1/24/2023	National Bank of Canada FI	59,000	$3.23M	0.0%	N/A	0.126%
1/24/2023	Moody Aldrich Partners LLC	19,994	$1.10M	0.2%	N/A	0.043%
12/8/2022	Bank of New York Mellon Corp	112,890	$3.84M	0.0%	+31.2%	0.241%
11/21/2022	California State Teachers Retirement System	36,386	$1.24M	0.0%	+22.7%	0.078%
11/16/2022	Fred Alger Management LLC	11,981	$0.41M	0.0%	N/A	0.026%
11/16/2022	Sandia Investment Management LP	5,000	$0.17M	0.0%	N/A	0.011%
11/16/2022	BNP Paribas Arbitrage SNC	14,618	$0.50M	0.0%	-34.7%	0.031%
11/15/2022	Alliancebernstein L.P.	24,528	$0.84M	0.0%	+14.6%	0.052%
11/15/2022	State Street Corp	547,622	$18.65M	0.0%	+11.1%	1.171%
11/15/2022	Two Sigma Investments LP	133,547	$4.55M	0.0%	+100.4%	0.286%
11/15/2022	Trexquant Investment LP	41,167	$1.40M	0.0%	+135.1%	0.088%
11/15/2022	Tri Locum Partners LP	209,248	$7.13M	2.0%	N/A	0.447%
11/15/2022	UBS Asset Management Americas Inc.	24,609	$0.84M	0.0%	-27.3%	0.053%
11/15/2022	Vanguard Group Inc.	1,740,593	$59.27M	0.0%	+32.8%	3.722%
11/15/2022	Perceptive Advisors LLC	430,000	$14.64M	0.4%	N/A	0.920%
11/15/2022	Price T Rowe Associates Inc. MD	1,462,424	$49.80M	0.0%	+221.2%	3.127%
11/15/2022	Quantamental Technologies LLC	14,725	$0.50M	0.2%	N/A	0.031%
11/15/2022	Logos Global Management LP	400,000	$13.62M	1.7%	N/A	0.855%
11/15/2022	Long Focus Capital Management LLC	292,000	$9.94M	1.0%	+0.7%	0.624%
11/15/2022	Marshall Wace LLP	750,840	$25.57M	0.1%	-25.3%	1.606%
11/15/2022	Ensign Peak Advisors Inc	170,034	$5.79M	0.0%	+137.8%	0.364%
11/15/2022	Bank of New York Mellon Corp	112,890	$3.84M	0.0%	+31.2%	0.241%
11/15/2022	Bellevue Group AG	41,634	$1.42M	0.0%	N/A	0.089%
11/15/2022	BlackRock Inc.	2,345,477	$79.86M	0.0%	+12.2%	5.016%
11/15/2022	Blueshift Asset Management LLC	5,942	$0.20M	0.0%	N/A	0.013%
11/15/2022	Commodore Capital LP	743,472	$25.32M	4.1%	N/A	1.590%
11/14/2022	Macquarie Group Ltd.	3,089	$0.12M	0.0%	-11.5%	0.007%
11/14/2022	Royal Bank of Canada	2,605	$89K	0.0%	+9.9%	0.006%
11/14/2022	Tudor Investment Corp Et Al	12,146	$0.41M	0.0%	N/A	0.026%
11/14/2022	Cubist Systematic Strategies LLC	117,175	$3.99M	0.0%	+478.8%	0.251%
11/14/2022	PDT Partners LLC	24,593	$0.84M	0.1%	-36.7%	0.053%
11/14/2022	Renaissance Technologies LLC	64,100	$2.18M	0.0%	-47.4%	0.137%
11/14/2022	RA Capital Management L.P.	958,980	$32.65M	0.7%	N/A	2.051%
11/14/2022	Ergoteles LLC	16,300	$0.56M	0.0%	-15.5%	0.035%
11/14/2022	Nuveen Asset Management LLC	132,245	$1.62M	0.0%	+35.7%	0.283%

Data available starting January 2016

Akero Therapeutics, Inc. operates as a cardio-metabolic nonalcoholic steatohepatitis company, which engages in developing pioneering medicines designed to restore metabolic balance and improve overall health. The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21, or FGF21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates and proteins throughout the body. The company was founded by Jonathan Young and Timothy Rolph on January 24, 2017 and is headquartered in South San Francisco, CA.

Today's Range

Now: $37.80

$36.09

$40.48

50 Day Range

MA: $44.23

$37.27

$49.50

52 Week Range

Now: $37.80

$7.52

$54.88

Volume

1,171,717 shs

Average Volume

602,441 shs

Market Capitalization

$1.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Akero Therapeutics?: Akero Therapeutics' top insider shareholders include:
Skorpios Trust (Major Shareholder)
Andrew Cheng (CEO)
Seth Loring Harrison (Director)
Timothy Rolph (Insider)
Jonathan Young (COO)
Catriona Yale (Insider)
William Richard White (CFO)
Kevin Bitterman (Director)
Learn More about top insider investors at Akero Therapeutics.
Who are the major institutional investors of Akero Therapeutics?: Akero Therapeutics' top institutional investors include:
Avidity Partners Management LP — 8.18%
Skorpios Trust — 7.00%
Alkeon Capital Management LLC — 6.94%
Price T Rowe Associates Inc. MD — 5.13%
Marshall Wace LLP — 3.22%
Geode Capital Management LLC — 1.35%
Learn More about top institutional investors of Akero Therapeutics stock.
Which institutional investors are selling Akero Therapeutics stock?: In the last quarter, AKRO stock was sold by these institutional investors:
Skorpios Trust
Atlas Venture Life Science Advisors LLC
Susquehanna International Group LLP
Two Sigma Investments LP
Simplex Trading LLC
Parallax Volatility Advisers L.P.
EAM Investors LLC
CSS LLC IL
In the previous year, company insiders that have sold Akero Therapeutics company stock include:
Skorpios Trust (Major Shareholder)
Andrew Cheng (CEO)
Seth Loring Harrison (Director)
Timothy Rolph (Insider)
Jonathan Young (COO)
Catriona Yale (Insider)
William Richard White (CFO)
Learn More investors selling Akero Therapeutics stock.
Which institutional investors are buying Akero Therapeutics stock?: During the last quarter, AKRO stock was purchased by institutional investors including:
Price T Rowe Associates Inc. MD
Marshall Wace LLP
Avidity Partners Management LP
Deutsche Bank AG
Millennium Management LLC
Artisan Partners Limited Partnership
Norges Bank
Silverarc Capital Management LLC

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

AKRO Insider Trading

Akero Therapeutics Insider Trading History Chart

Akero Therapeutics Share Price & Price History

Akero Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Akero Therapeutics (NASDAQ:AKRO)

Institutional Buying and Selling by Quarter

Akero Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Akero Therapeutics?

Who are the major institutional investors of Akero Therapeutics?

Which institutional investors are selling Akero Therapeutics stock?

Which institutional investors are buying Akero Therapeutics stock?